Skip to content

Surveillance of eosinophilic esophagitis in patients with bronchial asthma and upper gastrointestinal symptoms

Surveillance of eosinophilic esophagitis in patients with bronchial asthma and upper gastrointestinal symptoms - Eosinophilic esophagitis in patients with bronchial asthma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000010132
Enrollment
100
Registered
2013-02-27
Start date
2012-10-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bronchial asthma, eosinophilic esophagitis

Interventions

esophagogastroduodenoscopy

Sponsors

Saitama Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: patients with bronchial asthma and upper GI symptoms

Exclusion criteria

Exclusion criteria: systemic administration of glucocorcicoids

Design outcomes

Primary

MeasureTime frame
rate and degree of eosinophilic esophagitis in patients with bronchial asthma and upper gastrointestinal symptoms

Countries

Japan

Contacts

Public ContactHiroyuki Imaeda

Saitama Medical University Department of General Internal Medicine

imaedahi@saitama-med.ac.jp049-276-1667

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026